Focus Stocks

Facebook (FB)

Facebook (FB)


JP Morgan (JPM)

JP Morgan (JPM)


AutoZone (AZO)

AutoZone (AZO)


Yahoo (YHOO)

Yahoo (YHOO)


Apple (AAPL)

Apple (AAPL)


Featured Stories

Medtronic Reports Fourth Quarter Earnings

Medtronic Reports Fourth Quarter Earnings


Cracker Barrel Reports Earnings, Increases Guidance

Cracker Barrel Reports Earnings, Increases Guidance


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


Is Yum! Brands Closing in to Support?

Is Yum! Brands Closing in to Support?


Intuitive Surgical Bullish Signs

Intuitive Surgical Bullish Signs


Webcast of QIAGEN N.V.'s Fourth Quarter and Year End 2011 Financial Results Call Set for February 1, 2012

VENLO, Netherlands, Jan. 24, 2012 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) today announced the Webcast of its fourth quarter and year-end 2011 financial results call. The Webcast will take place at 9:30 a.m. ET on Wednesday, February 1, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

What: Webcast of QIAGEN's fourth quarter and year-end 2011 financial results call
         
When:  9:30 a.m. ET on February 1  
         
Where:  The Webcast is accessible at www.qiagen.com/goto/ConferenceCall
         
How:   Log on to the Web at the address above

The corresponding presentation slides will be available for download in the investor relations section of QIAGEN's Web site at www.qiagen.com/goto/ConferenceCall.

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics.

QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.

The QIAGEN N.V. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3692

CONTACT:  QIAGEN N.V.
          
 This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
 
          phone +49 2103 2911709

QIAGEN N.V. Logo



Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits. Try it FREE!

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Stock Market

Loading
Chart
o Dow Jones 12,496.15 ▼6.66 (-0.05%)
o S&P 500 1,318.86 ▲2.23 (0.17%)
o NASDAQ 2,850.12 ▲11.04 (0.39%)
INDEXDJX:.DJI

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:12,496.15 Trade time:4:05PM EDT Value change:▼6.66 (-0.05%)
INDEXSP:.INX

S&P 500

Company ID [INDEXSP:.INX] Last trade:1,318.86 Trade time:4:33PM EDT Value change:▲2.23 (0.17%)
INDEXNASDAQ:.IXIC

NASDAQ

Company ID [INDEXNASDAQ:.IXIC] Last trade:2,850.12 Trade time:5:16PM EDT Value change:▲11.04 (0.39%)
Copyright © 2011 TradersHuddle.com. All Rights Reserved.